2-Isopropylmalic acid



Compound IDCDAMM01354
Common name2-Isopropylmalic acid
IUPAC name2-hydroxy-2-propan-2-ylbutanedioic acid
Molecular formulaC7H12O5

Experimental data

Retention time4.09
Adduct[M+H]+
Actual mz177.077
Theoretical mz177.075
Error12.56
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.8072

Identifiers and class information

Inchi keyBITYXLXUCSKTJS-ZETCQYMHSA-N
SmilesO=C(O)CC(O)(C(=O)O)C(C)C
SuperclassLipids and lipid-like molecules
ClassFatty Acyls

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)2
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)176.169
Computed dipole moment(dipole)10.011
Total solvent accessible surface area (SASA)364.081
Hydrophobic component of SASA (FOSA)170.871
Hydrophilic component of SASA (FISA)193.21
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)592.144
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)3.75
Free energy of solvation of dipole (dip^2/V)0.169251
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0145663
Globularity descriptor (glob)0.936667
Predicted polarizability in cubic angstroms (QPpolrz)14.333
Predicted hexadecane/gas partition coefficient (QPlogPC16)5.856
Predicted octanol/gas partition coefficient (QPlogPoct)11.521
Predicted water/gas partition coefficient (QPlogPw)7.429
Predicted octanol/water partition coefficient (QPlogPo/w)0.572
Predicted aqueous solubility (QPlogS)-0.93
Conformation-independent predicted aqueous solubility (CIQPlogS)-1.401
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)1.058
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)9.352
Predicted brain/blood partition coefficient (QPlogBB)-1.206
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)5.129
Predicted skin permeability, log Kp (QPlogKp)-4.6
PM3 calculated ionization potential (IP(ev))10.882
PM3 calculated electron affinity (EA(eV))-0.589
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)-0.938
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)47.669
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)110.265
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P36544CHRNA7Neuronal acetylcholine receptor protein alpha-7 subunitT34429SwissTargetPrediction
Q96KS0EIT6HIF-prolyl hydroxylase 1T53904SwissTargetPrediction
Q6B0I6KDM4DLysine-specific demethylase 4DT17036SwissTargetPrediction
O15054KDM6BLysine-specific demethylase 6BT56057SwissTargetPrediction
P04035HMGCRHMG-CoA reductaseT53585SwissTargetPrediction
Q86YT5SLC13A5Solute carrier family 13 member 5T81547SEA
P53396ACLYATP-citrate synthaseT52189SwissTargetPrediction and SEA
Q9GZT9EGLN1Egl nine homolog 1T32880SwissTargetPrediction

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T34429DI0101Corneal disease[ICD-11: 9A76-9A78]P36544CHRNA7
T34429DI0370Schizophrenia[ICD-11: 6A20]P36544CHRNA7
T53904DI0010Acute disease anaemia[ICD-11: 3A90]Q96KS0EIT6
T53585DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P04035HMGCR
T53585DI0102Coronary atherosclerosis[ICD-11: BA52]P04035HMGCR
T53585DI0128Dyslipidemia[ICD-11: 5C80-5C81]P04035HMGCR
T53585DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P04035HMGCR
T53585DI0275Multiple sclerosis[ICD-11: 8A40]P04035HMGCR
T53585DI0287Myocardial infarction[ICD-11: BA41-BA43]P04035HMGCR
T53585DI0324Pain[ICD-11: MG30-MG3Z]P04035HMGCR
T52189DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P53396ACLY

Copyright © 2025